ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like CMC Biologics to Hire 100 to 150 Employees in Washington July 6, 2017 Life Science Companies are Litigation Targets for Unhappy Investors February 22, 2018 Biotech Vets Launch With $38 Million and Will be Helmed By Biogen Alum February 26, 2017
